EDGAR Filing Documents for 0001564590-21-014393

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001564590-21-014393

Filing Date

2021-03-19

Accepted

2021-03-19 16:31:19

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	srne-s3a.htm	S-3/A	395621
2	GRAPHIC	gguho3ejyrji000002.jpg	GRAPHIC	9950
3	GRAPHIC	gguho3ejyrji000001.jpg	GRAPHIC	9950
	Complete submission text file	0001564590-21-014393.txt		424406

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121

Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)